⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PPCB News
Propanc Biopharma, Inc. Common Stock
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
globenewswire.com
PPCB
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
globenewswire.com
PPCB
Form 8-K
sec.gov
PPCB
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
globenewswire.com
PPCB
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program
globenewswire.com
PPCB
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
globenewswire.com
PPCB
ShareStructure.io Announces Investor Education Platform on Public Company Financing Activity.
globenewswire.com
EDHL
PPCB
GLXG
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
globenewswire.com
PPCB
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
globenewswire.com
PPCB
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
globenewswire.com
PPCB